Innovation | Ophthalmology Innovation Source

Ophthalmic Innovation 2013 – “A View from the AAO”

David Parke, CEO for the American Academy of Ophthalmology, speaks to the audience of the 5th Annual Ophthalmology Innovation Summit @ AAO, about the importance, benefits and overall successes surrounding the use of clinical registries, namely the IRIS Registry. Highlighting the value proposition for ophthalmologists, David shares the Academy’s hope for the registry to reduce…

Alternative Financing Strategies

Charles Warden, Managing Director for Versant Ventures, initiates this finance focused panel by detailing the funding gap that has been referred to often at the 5th Annual Ophthalmology Innovation Summit @ AAO. Gaining insights from Luke Duster of Capital Royalty, Gregory Shearer of Healthios Capital Markets, Brian Demmert of Armentum Partners and Buzz Benson of…

The Ophthalmology Market – “A View from the Public Sector”

Jeffrey Hoffman, Managing Director and Head of West Coast Healthcare Investment Banking for JPMorgan, gladly addresses the audience at the 5th Annual Ophthalmology Innovation Summit with a promising outlook. Expanding on the rise of individual company risks, Jeffrey shares specific increases in the biotech and life sciences markets, as they recover from a 10-year lull.…

2013 Ophthalmology Innovation Summit Innovator Awards

William J. Link PhD, Managing Director for Versant Ventures, announces the winners of the 2013 OIS Innovator Award. Describing the caliber and achievement that merits this award, Bill recognizes Thomas Burns, President & CEO for Glaukos, and Richard Hill MD, Co-Founder for Glaukos, for their high impact ophthalmic innovations that have successfully improved the lives…

The NEI Continues to Explore the Root Cause of Glaucoma

Ophthalmic Innovation 2013 – “A View from the NEI” Paul Sieving, Director for the National Eye Institute, leads the attendees at the 5th Annual Ophthalmology Innovation Summit @ AAO through a overview of the organizations goals and accomplishments. Sharing the institute’s focus on discovering the cause of Glaucoma, Paul continues to share highlights on the…

CheckedUp Digitizes Communication in Eye Care

Richard Awdeh MD, Founder & CEO for CheckUp, begins by sharing the high number of patients that ophthalmologists see each day and the incredibly low average of time an ophthalmologist has to spend with each patient. Utilizing technology to enhance communication between patient and doctor, Richard explains how his digital communication platform can enhance the…

More Value to Ophthalmic Innovators Working with Strategic Investors

Evan Norton of Abbott Ventures sees a trend in which corporate investors are moving up their game to an earlier development stage, which could result in more funding opportunities for innovators. “As a strategic investor, we don’t invest in things unless we see a path for them to be acquired by Abbott. We do, however,…

VC Says There Are Many ‘Unmet Needs’ in Ophthalmology Space

SAN FRANCISCO — The second annual Ophthalmology Innovation Summit (OIS) was held in conjunction with the American Society of Cataract and Refractive Surgeons (ASCRS; Reston, Virginia). International Business Forum (Massapequa, New York) organized the meeting. The purpose of the OIS conference is to support innovation by facilitating deal-flow and business partnerships between CEOs of young…

OIS@ASCRS 2013 Executive Summary – Eye on Innovation

The Second Annual OIS@ASCRS – Ophthalmology Innovation Summit at the American Society of Cataract and Refractive Surgery was held in San Francisco on April 18, 2013. The conference attracted 325 attendees from 29 US states and 21 countries. The purpose of OIS is to create an ecosystem of clinical, technology and business. Uniting this diverse…

Innovation in Ophthalmology Pushes Forward

SAN FRANCISCO — The future of innovation in ophthalmology is promising, with more forward movement than drag, according to a speaker here. “The tailwinds are stronger than the headwinds,” William J. Link, PhD, managing director of Versant Ventures, told colleagues interested in supporting innovation in the ophthalmic space at the Ophthalmology Innovation Summit. Key criteria…

Funding Ophthalmic Innovation

Angela MacFarlane, President & CEO for ForSight Labs and Emmett Cunningham, Partner for Clarus Ventures co-moderate a segment on funding opportunities for innovative products and procedures in the Ophthalmic space, at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Lending their expert insights on the funding process are panelists Calvin W. Roberts, MD,…

Introduction to MIGS: Micro-Invasive Glaucoma Surgery

Dr. Gil Kliman, Managing Director for InterWest Partners, introduces the conference’s segment on MIGS at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Giving the attendees an overview of the market and an in depth view of the different approaches, Gil sets the stage for further discussion around Micro-Invasive Glaucoma Surgery. Presenter: Gilbert…